Stammdaten
Unternehmen & Branche
| Name | Entera Bio Ltd. |
|---|---|
| Ticker | ENTXW |
| CIK | 0001638097 |
| Sektor | Healthcare |
| Industrie | Biotechnology |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Marktkapitalisierung | 0 USD |
| Beta | 0,00 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 42,000 | -11,439,000 | 0.25 | 15,993,000 | 13,101,000 |
| 2025-09-30 | 10-Q | 0 | -3,200,000 | 0.07 | 17,407,000 | 15,234,000 |
| 2025-06-30 | 10-Q | 0 | -2,656,000 | 0.06 | 19,667,000 | 17,256,000 |
| 2025-03-31 | 10-Q | 42,000 | -2,567,000 | 0.06 | 21,600,000 | 19,379,000 |
| 2024-12-31 | 10-K | 181,000 | -9,541,000 | 0.25 | 9,390,000 | 8,080,000 |
| 2024-09-30 | 10-Q | 42,000 | -3,021,000 | 0.08 | 7,741,000 | 6,452,000 |
| 2024-06-30 | 10-Q | 57,000 | -2,145,000 | 0.06 | 10,035,000 | 8,532,000 |
| 2024-03-31 | 10-Q | 0 | -2,017,000 | 0.05 | 10,239,000 | 8,863,000 |
| 2023-12-31 | 10-K | 0 | -8,889,000 | 0.31 | 11,765,000 | 10,386,000 |
| 2023-09-30 | 10-Q | 0 | -2,379,000 | 0.08 | 8,565,000 | 6,236,000 |
| 2023-06-30 | 10-Q | 0 | -2,325,000 | 0.08 | 10,445,000 | 8,232,000 |
| 2023-03-31 | 10-Q | 0 | -2,190,000 | 0.08 | 11,606,000 | 10,080,000 |
| 2022-12-31 | 10-K | 134,000 | -13,071,000 | 0.45 | 13,127,000 | 11,754,000 |
| 2022-09-30 | 10-Q | 8,000 | -3,067,000 | 0.11 | 15,540,000 | 14,312,000 |
| 2022-06-30 | 10-Q | 44,000 | -3,185,000 | 0.11 | 19,088,000 | 17,269,000 |
| 2022-03-31 | 10-Q | 68,000 | -3,784,000 | 0.13 | 22,312,000 | 19,745,000 |
| 2021-12-31 | 10-K | 571,000 | -12,187,000 | 0.47 | 25,987,000 | 22,565,000 |
| 2021-09-30 | 10-Q | 140,000 | -3,214,000 | 0.11 | 26,276,000 | |
| 2021-06-30 | 10-Q | 109,000 | -2,577,000 | 0.10 | 26,277,000 | |
| 2021-03-31 | 10-Q | 157,000 | -2,296,000 | 15,650,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | Germano Geno J | Director | Open Market Purchase | 20,000 | 1.30 | 26,000.00 | +136,6% | |
| 2026-02-12 | Rubin Steven D | Director | Open Market Purchase | 5,000 | 1.49 | 7,450.00 | +39,1% | |
| 2026-02-10 | Germano Geno J | Director | Open Market Purchase | 20,000 | 1.49 | 29,800.00 | +156,6% | |
| 2026-02-09 | Rubin Steven D | Director | Open Market Purchase | 10,000 | 1.20 | 12,000.00 | +63,1% | |
| 2025-12-29 | Toledano Miranda Jayne | Director, Officer, Chief Executive Officer | Open Market Purchase | 11,000 | 1.81 | 19,912.20 | +104,6% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.